AJP - Heart AJP: Advances in Physiology Education
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (August 19, 2005). doi:10.1152/ajpheart.00769.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/1/H46    most recent
00769.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Parmentier, J.-H.
Right arrow Articles by Malik, K. U
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Parmentier, J.-H.
Right arrow Articles by Malik, K. U
Submitted on July 20, 2005
Accepted on December 31, 1969

Angiotensin II stimulates phospholipase D through PKC{zeta} activation in VSMC. Implications in adhesion, spreading and hypertrophy

Jean-Hugues Parmentier1*, Zoran Pavicevic1, and Kafait U Malik1

1 Pharmacology, University of Tennessee Health Science Center, Memphis, TN, USA

* To whom correspondence should be addressed. E-mail: jparmentier{at}utmem.edu.

Angiotensin II (Ang II) stimulates phospholipase D (PLD) activity and growth of vascular smooth muscle cells (VSMC). The atypical protein kinase C{zeta} (PKC{zeta}) plays a central role in the regulation of cell survival and proliferation. This study was conducted to determine the relationship between Ang II-induced activation of PKC{zeta} and PLD and their implication in VSMC adhesion, spreading and hypertrophy. Ang II stimulated PKC{zeta} activity with maximal activation at 30 sec followed by a decline in its activity to 45% above basal at 5 min. Inhibition of PKC{zeta} activity with a myristoylated pseudosubstrate peptide or overexpression of a kinase-inactive form of PKC{zeta} decreased Ang II-induced PLD activity. Moreover, depletion of PKC{zeta} with selective antisense oligonucleotides also decreased Ang II-induced PLD activity. Interaction between PLD2 and PKC{zeta} in VSMC was detected by co-immunoprecipitation. Ang II-induced PLD activity was inhibited by the primary alcohol n-butanol, but not the tertiary alcohol, t-butanol. The functional significance of PKC{zeta} and PLD2 in VSMC adhesion, spreading and hypertrophy was investigated. Inhibition of PKC{zeta} and PLD2 activity or expression attenuated VSMC adhesion to collagen I and Ang II-induced cell spreading and hypertrophy. These results demonstrate that Ang II-induced PLD activation is regulated by PKC{zeta} and suggest a crucial role of PKC{zeta}-dependent PLD2 in VSMC functions such as adhesion, spreading and hypertrophy, which are associated with the pathogenesis of atherosclerosis and malignant hypertension.




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J.-H. Parmentier, C. Zhang, A. Estes, S. Schaefer, and K. U. Malik
Essential role of PKC-{zeta} in normal and angiotensin II-accelerated neointimal growth after vascular injury
Am J Physiol Heart Circ Physiol, October 1, 2006; 291(4): H1602 - H1613.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. Ushio-Fukai
Nuclear Phospholipase D1 in Vascular Smooth Muscle: Specific Activation by G Protein-Coupled Receptors
Circ. Res., July 21, 2006; 99(2): 116 - 118.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.